ID: ALA1172240

Max Phase: Preclinical

Molecular Formula: C13H19NO

Molecular Weight: 205.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C1CCC2(N1)C1CC3CC(C1)CC2C3

Standard InChI:  InChI=1S/C13H19NO/c15-12-1-2-13(14-12)10-4-8-3-9(6-10)7-11(13)5-8/h8-11H,1-7H2,(H,14,15)

Standard InChI Key:  CGXGSOKIYGVUOZ-UHFFFAOYSA-N

Associated Targets(non-human)

Matrix protein 2 436 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 205.30Molecular Weight (Monoisotopic): 205.1467AlogP: 2.09#Rotatable Bonds: 0
Polar Surface Area: 29.10Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.52CX LogD: 1.52
Aromatic Rings: 0Heavy Atoms: 15QED Weighted: 0.64Np Likeness Score: 0.68

References

1. Eleftheratos S, Spearpoint P, Ortore G, Kolocouris A, Martinelli A, Martin S, Hay A..  (2010)  Interaction of aminoadamantane derivatives with the influenza A virus M2 channel-docking using a pore blocking model.,  20  (14): [PMID:20570509] [10.1016/j.bmcl.2010.05.049]

Source